← back to search

Chunyang Liu

Nanjing University of Chinese Medicine · CN
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research focused on Intracerebral hemorrhage and Programmed cell death, with related work in Indoline, microRNA, Artificial intelligence. Notable publications include 'Discovery of 4-Arylindolines Containing a Thiazole Moiety as Potential Antitumor Agents Inhibiting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction', 'Discovery of the programmed cell death-1/programmed cell death-ligand 1 interaction inhibitors bearing an indoline scaffold', and 'The Role of MicroRNAs in Therapeutic Resistance of Malignant Primary Brain Tumors'.
h-index
citations
194
works
8
NIH funding
primary concept
email

Recent publications

Predictors of affective disturbances and cognitive impairment following small spontaneous supratentorial intracerebral hemorrhage
European Journal of Neurology 2024cited by 6position: middledoi
Unsupervised Skin Lesion Segmentation via Structural Entropy Minimization on Multi-Scale Superpixel Graphs
2023cited by 13position: middledoi
Lateral Habenula Neurons Signal Cold Aversion and Participate in Cold Aversion
Neurochemical Research 2023cited by 4position: middledoi
Irregular shape as an independent predictor of prognosis in patients with primary intracerebral hemorrhage
Scientific Reports 2022cited by 11position: firstdoi
Total intracranial volume as a covariate for predicting prognosis in patients with primary intracerebral hemorrhage
Clinical Neurology and Neurosurgery 2022cited by 6position: middledoi
Discovery of 4-Arylindolines Containing a Thiazole Moiety as Potential Antitumor Agents Inhibiting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction
Journal of Medicinal Chemistry 2021cited by 56position: middledoi
The Role of MicroRNAs in Therapeutic Resistance of Malignant Primary Brain Tumors
Frontiers in Cell and Developmental Biology 2021cited by 48position: middledoi
Discovery of the programmed cell death-1/programmed cell death-ligand 1 interaction inhibitors bearing an indoline scaffold
European Journal of Medicinal Chemistry 2019cited by 50position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Guang Yang · Liaoning Technical University5 papers (2021–2024)Enzhou Lu · Harbin Medical University3 papers (2022–2024)Qiuyi Jiang · Harbin Medical University3 papers (2022–2024)Lu Wang · Harbin Medical University3 papers (2022–2023)Chao Yuan · Guangzhou University of Chinese Medicine2 papers (2022–2022)Huan Xiang · Harbin Medical University2 papers (2022–2023)Yanchao Liang · Shandong University2 papers (2022–2023)Mingze Qin · Shenyang Pharmaceutical University2 papers (2019–2021)Yanchao Liang · Harbin Medical University2 papers (2021–2024)Yunlei Hou · Shenyang Pharmaceutical University2 papers (2019–2021)Ye Tian · Southern Medical University2 papers (2019–2021)Rui Liu · Nanjing University of Chinese Medicine2 papers (2022–2024)Xun Xu · State Key Laboratory For Conservation and Utilization of Subtropical Agro-Bioresources2 papers (2022–2022)Yanfang Zhao · University of Alabama at Birmingham2 papers (2019–2021)Haopeng Zhang · University of California, Davis2 papers (2022–2022)Xia Wu · Zhejiang Chinese Medical University2 papers (2019–2021)Daming Zhang · Shanxi Medical University2 papers (2022–2022)Jingxian Sun · Harbin Medical University2 papers (2022–2022)Lei Liu · Fudan University1 papers (2021–2021)Boxian Zhao · Harbin Medical University1 papers (2022–2022)